Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | HSPD1 | P10809 | 1/20 | 1.00 |
| ▸ | HSPE1 | P61604 | 1/20 | 1.00 |
| ▸ | TST | Q16762 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | PPM1A | P35813 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.46 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.46 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8470179 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22749131 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| Ascorbyl Palmitate SCHEMBL14429918 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22749146 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22749133 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL8472638 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| Ascorbyl Palmitate SCHEMBL11170086 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| Ascorbyl Stearate SCHEMBL4574542 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL1762372 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL1762325 | 1.00 | MAPT (1.00) | MAPTHSPD1HSPE1TSTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3928619-A1 | A METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | Decco Worldwide Post-Harvest Holdings B.V. (NL) | 2021-12-29 | — | — | EP | claimed |
| US-20250143331-A1 | METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | DECCO WORLDWIDE POST-HARVEST HOLDINGS B.V. (NL) | 2025-05-08 | — | — | US | disclosed |
| US-20230200404-A1 | METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | DECCO WORLDWIDE POST-HARVEST HOLDINGS B.V. (NL) | 2023-06-29 | — | — | US | disclosed |
| US-20220259500-A1 | AGENT FOR PREVENTION OF DECOMPOSITION OF BIOPYRRIN | RESVO INC. (JP) | 2022-08-18 | — | — | US | disclosed |
| EP-3998325-A1 | AGENT FOR PREVENTION OF DECOMPOSITION OF BIOPYRRIN | Resvo Inc. (JP) | 2022-05-18 | — | — | EP | disclosed |
| EP-3928619-A1 | A METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | Decco Worldwide Post-Harvest Holdings B.V. (NL) | 2021-12-29 | — | — | EP | disclosed |
| EP-3684177-A1 | A METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | Decco Worldwide Post-Harvest Holdings B.V. (NL) | 2020-07-29 | — | — | EP | disclosed |
| US-20200214305-A1 | A METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | DECCO WORLDWIDE POST-HARVEST HOLDINGS B.V. (NL) | 2020-07-09 | — | — | US | disclosed |
| EP-2928841-B1 | ANTI-SAGGING GYPSUM PRODUCT AND A METHOD TO MANUFACTURE | SAINT GOBAIN PLACO (FR) | 2019-11-13 | — | — | EP | disclosed |
| US-10273408-B2 | Wavelength conversion member, backlight unit including wavelength conversion member, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2019-04-30 | — | — | US | disclosed |
| WO-2019058211-A1 | A METHOD FOR TREATING AND CONTROLLING POST-HARVEST PHYSIOLOGICAL DISORDERS IN FRUIT VIA EDIBLE COATINGS | DECCO WORLDWIDE POST-HARVEST HOLDINGS B.V. (NL) | 2019-03-28 | — | — | WO | disclosed |
| US-20180072949-A1 | WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT INCLUDING WAVELENGTH CONVERSION MEMBER, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2018-03-15 | — | — | US | disclosed |
| US-20180072949-A1 | WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT INCLUDING WAVELENGTH CONVERSION MEMBER, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2018-03-15 | — | — | US | disclosed |
| US-20170368052-A1 | CRYSTAL FORMS OF APOMORPHINE AND USES THEREOF | NEURODERM, LTD. (IL) | 2017-12-28 | — | — | US | disclosed |
| CN-104345098-B | A kind of method measuring antioxidant content in tablet of tibolone | CHINA RESOURCES ZIZHU PHARMACEUTICAL CO., LTD. (CN) | 2016-04-13 | — | — | CN | disclosed |
| CN-104345098-A | Method for determining antioxidant content in tibolone tablets | CHINA RESOURCES ZIZHU PHARMACEUTICAL CO LTD | 2015-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170368052-A1 | CRYSTAL FORMS OF APOMORPHINE AND USES THEREOF | PARK7, SNCA, SLC6A3 | MAPT 22/4885HSPD1 1143/4885HSPE1 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.